Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • TARMED and TARDOC

Decision for physician tariff postponed

    • Education
    • General Internal Medicine
    • News
    • Prevention and health care
    • RX
  • 2 minute read

The need to revise the outdated TARMED physician tariff is undisputed. Now, however, the Federal Council has decided to postpone approval of TARDOC. A procedure that the tariff partners curafutura, FMH and MTK see as a missed opportunity for the introduction of an appropriate tariff that corresponds to the current technical realities of outpatient medicine.

TARMED has been in force since 2004, which means that medical services are increasingly being remunerated in an unbalanced and outdated manner. This disadvantages patients because some services are overpriced while others are underpaid and no longer cover costs. Important services, for example in the area of primary care or psychiatry, continue to be inappropriately mapped and the further development of interprofessionalism is hampered. Medical services must be reflected in the tariff in a balanced and appropriate manner, as also required by the Health Insurance Act. This is the only way to ensure good, high-quality patient care. The decision of the Federal Council to postpone the approval is therefore met with incomprehension. The tariff partners curafutura, FMH and MTK will now analyze the decision of the Federal Council to determine to what extent the demands for adjustments to the TARDOC are at all appropriate and feasible, since this fulfills the legal criteria in its current version. The TARDOC is backed by the FMH, the majority of service providers and the majority of insured persons. Meanwhile, children’s hospitals are also calling for the rapid implementation of TARDOC. The concept of cost-neutral introduction of the TARDOC ensures that no additional costs are incurred as a result of the tariff change from TARMED to TARDOC. Therefore, the tariff partners clearly disagree with the Federal Council on the important criteria.

The further planned procedure comprises three steps:

  1. The BR call will be implemented by the end of 2021. We will make what is feasible by the end of 2021 possible. We will then realize what is not feasible by the end of 2021. However, we are not doing this alone, but – as the BR wants – with the personal support of the Minister of Health and together with the other collective bargaining partners. We call on H+ and Santésuisse, with the help of the tariff office ats-tms as a hub, to start cooperation materially and formally.

  2. A new, national tariff organization will be created, analogous to the demand of BR Berset. The TARDOC is set as a single service tariff with entry into force on 1.1.2023.
  3. The other collective bargaining partners are called upon to implement their promises.

We expect a proposal on flat rates by August 20, 2021, which is appropriate in terms of maturity and in line with the TARDOC maturity level, so that they can be submitted with all concepts and contracts at the end of 2021 and also be put into effect on January 1, 2023.

 

Source: “Physician tariff: Decision of the Federal Council is incomprehensible and not comprehensible”, 01.07.2021, FMH

 

InFo NEUROLOGY & PSYCHIATRY 2021; 19(4): 36 (published 8/23-21, ahead of print).

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • tardoc
  • TARMED
Previous Article
  • Sports injuries

Tendinopathies – degeneration and regeneration of the tendon

  • Congress Reports
  • General Internal Medicine
  • Orthopedics
  • RX
  • Sports Medicine
View Post
Next Article
  • Diabetes in Motion

CME video training on modern diabetes management

  • CME continuing education
  • Education
  • Endocrinology and Diabetology
  • Partner Content
  • RX
View Post
You May Also Like
View Post
  • 14 min
  • Focus Update 2026

Echocardiography in Cardio-Oncology

    • RX
    • Cardiology
    • Education
    • Oncology
    • Radiology
    • Studies
View Post
  • 4 min
  • Physical activity with IBD

Sport is not murder, but it doesn’t help either

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Sports Medicine
    • Studies
View Post
  • 3 min
  • White and Black Skin Cancer

Biology and Modern Therapeutic Approaches

    • RX
    • Dermatology and venereology
    • Education
    • Oncology
    • Prevention and health care
    • Studies
    • Surgery
View Post
  • 5 min
  • Highlights from the AAD Annual Meeting

Atopic Dermatitis: Interesting News on Drug Candidates in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 6 min
  • Autoimmune Liver Diseases

Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 8 min
  • Myelofibrosis

Mutations and Molecular Diagnostics in Treatment Decisions

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
View Post
  • 5 min
  • Psoriasis in the Age of Precision Medicine

Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?

    • RX
    • Cardiology
    • Congress Reports
    • Dermatology and venereology
    • Gastroenterology and Hepatology
    • Nutrition
    • Rheumatology
    • Studies
View Post
  • 13 min
  • The AMALFI study and the limits of digital screening for atrial fibrillation

Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?

    • RX
    • Cardiology
    • Education
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.